Who can get the new weight loss pill? Everything you need to know about the UK's first approved Wegovy tablet

GB News - News

source • 1 mention

Britain has become the first country in the United Kingdom to authorise an oral tablet form of the popular weight loss drug semaglutide, marketed as Wegovy.The Medicines and Healthcare products Regulatory Agency granted approval yesterday for what represents a landmark moment in obesity treatment options.This marks the nation's inaugural GLP-1 receptor agonist pill designed specifically for weight management purposes.The decision opens a new chapter for patients seeking alternatives to injectable versions of the medication, which have faced significant supply challenges in recent years.

Supported by 1 story

TRENDING Stories Videos Your Say The tablet formulation must be prescribed by a healthcare professional and cannot be purchased over the counter.The medication may be prescribed to adults living with obesity, defined as having a Body Mass Index of 30 or greater.Those carrying excess weight with a BMI between 27 and 30 also qualify, provided they suffer from at least one health condition linked to their...

Supported by 1 story